Ethypharm

Ethypharm Expands in China’s IBD Market with Acquisition of Mesalazine Suppository

Ethypharm, a France-based pharmaceutical company, has announced that its Chinese subsidiary, Shanghai Ethypharmaceuticals Ltd, has...